Cambiar Investors LLC Cuts Stake in Amdocs Limited $DOX

Key Points

• Cambiar Investors LLC reduced its holdings in Amdocs Limited by 11.1% in the 1st quarter, owning 101,887 shares worth approximately $9.32 million after selling 12,755 shares.
• Amdocs reported an EPS of $1.72 for the most recent quarter, exceeding analysts' estimates by $0.01, despite a 8.4% decline in revenue year-over-year.
• The company declared a quarterly dividend of $0.527 per share, with a yield of 2.4%, to be paid on October 31st to shareholders of record on September 30th.

Cambiar Investors LLC lowered its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 11.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 101,887 shares of the technology company's stock after selling 12,755 shares during the period. Cambiar Investors LLC owned approximately 0.09% of Amdocs worth $9,323,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new stake in Amdocs in the first quarter worth about $27,000. AdvisorNet Financial Inc lifted its stake in Amdocs by 382.9% in the first quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock worth $31,000 after purchasing an additional 268 shares during the last quarter. NBC Securities Inc. bought a new stake in Amdocs in the first quarter worth about $31,000. Cullen Frost Bankers Inc. bought a new stake in Amdocs in the first quarter worth about $39,000. Finally, Tower Research Capital LLC TRC lifted its stake in Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after purchasing an additional 208 shares during the last quarter. Institutional investors own 92.02% of the company's stock.

Amdocs Stock Up 1.9%

NASDAQ:DOX traded up $1.64 during trading hours on Friday, reaching $88.25. The company's stock had a trading volume of 195,776 shares, compared to its average volume of 716,163. The company has a market capitalization of $9.96 billion, a P/E ratio of 17.90, a price-to-earnings-growth ratio of 1.59 and a beta of 0.51. Amdocs Limited has a 12 month low of $78.61 and a 12 month high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.16 and a current ratio of 1.22. The stock has a 50 day moving average price of $89.22 and a two-hundred day moving average price of $88.76.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. The company had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. Amdocs's revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.62 earnings per share. Equities analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's payout ratio is currently 42.80%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on DOX shares. Wolfe Research started coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Amdocs presently has a consensus rating of "Buy" and an average price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.